A Social Emotion Regulation Intervention in MS
Study Details
Study Description
Brief Summary
The current project will examine effectiveness of an intervention based on the concept of the social regulation of emotion. The intervention is designed to improve well-being in individuals with MS by leveraging participants' existing social support. Effectiveness will be tested on a sample of 42 individuals with MS, half of whom will receive the intervention and half of which will receive an inactive control. Investigators will document changes resulting from treatment on self-reported levels of stress, depression, and quality of life. Intervention evaluation will expand scientific knowledge of emotion regulation disruption in MS, and potentially identify a novel and highly efficient means of treatment.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Multiple sclerosis (MS) is a progressive and debilitating neurological disease which not only affects a patient's physical health, but also adversely affects their mental health. Depressed mood is common in MS, and poor mental health in individuals with MS has wide-ranging consequences on social relationships and community integration. The preponderance of negative emotions and sparsity of positive emotions in MS are attributable in part to ineffective emotion regulation strategies. Thus, the clinical trial seeks to evaluate the effectiveness of an intervention which instructs individuals on using the social regulation of emotion.
The social regulation of emotion occurs when a one's emotional state benefits from an interaction with another person, such as when seeking comfort from a trusted friend. The current intervention was designed to leverage existing social relationships for emotional support in a manner which should strengthen the perception of social support and also reinforce existing relationships. The primary goal of this trial is to examine changes in mental well-being after treatment.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Experimental Participants in the experimental group will receive training in utilizing social regulation of emotion strategies in an individualized format. They will meet with an interventionist for 5 weeks (1 in-person session and 4 telephone sessions) for 1-1.5 hours each week, and keep a journal documenting their emotion challenges and regulation strategy use. |
Behavioral: Social Emotion Regulation Strategy Development
Participants will work one-on-one with an interventionist to develop goals (in the form of implementation intentions) to develop social emotion regulation strategies to combat frequent emotional challenges.
|
| Other: Control Participants in the control group will not receive training in utilizing social regulation of emotion strategies. While they will still meet with the interventionist on the same schedule and for approximately the same length of time, they will simply be asked to report the emotion regulation strategies that they naturally employ. They will also keep a journal documenting their emotion challenges and regulation strategy use. |
Behavioral: Control
Participants will work one-on-one with an interventionist to report on their frequent emotional challenges, and report the emotion regulation strategies that they frequently use to combat them.
|
Outcome Measures
Primary Outcome Measures
- Well-being: Depression [Scores will be assessed at two time-points, baseline (week 1) and post-intervention (week 6)]
Change in scores on a self-report questionnaire of depression (the Center for Epidemiologic Studies Depression Scale, a 20-item scale with higher scores indicating greater depression)
- Well-being: Stress [Scores will be assessed at two time-points, baseline (week 1) and post-intervention (week 6)]
Change in scores on a self-report questionnaire of stress (the Perceived Stress Scale, a 10-item scale with higher scores reflecting higher stress)
- Well-being: Quality of life [Scores will be assessed at two time-points, baseline (week 1) and post-intervention (week 6)]
Change in scores on a self-report questionnaire of quality of life (the Satisfaction with Life Scale, a five item scale where higher scores reflect higher satisfaction)
Secondary Outcome Measures
- Perceived social support [Scores will be assessed at two time-points, baseline (week 1) and post-intervention (week 6)]
Change in scores on a self-report questionnaire of perceived social support (the Multidimensional Scale of Perceived Social Support, a 12-item scale where higher scores reflect greater support)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Multiple Sclerosis diagnosis
-
English language fluency
Exclusion Criteria:
-
currently taking steroids or benzodiazepines
-
within 30 days of an exacerbation
-
history of substance abuse
-
diagnosis of bipolar, schizophrenia, epilepsy, stroke
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Kessler Foundation | East Hanover | New Jersey | United States | 07936 |
Sponsors and Collaborators
- Kessler Foundation
Investigators
- Principal Investigator: Katie Lancaster, PhD, Kessler Foundation
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PC 8-19